$6.38
▲ +$0.27
(+4.42%)
Vol 167K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$40.9M
ROE
-178.5%
Margin
-4796.7%
D/E
222.96
Beta
0.25
52W
$1–$6
Wall Street Consensus
9 analysts · Apr 20263
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
77.8%
Buy Rating
Price Chart
Similar Stocks
ALDX
Aldeyra Therapeutics Inc
$99.9M
SPRB
Spruce Biosciences, Inc
$93.2M
COYA
Coya Therapeutics Inc
$121.4M
PYXS
Pyxis Oncology Inc
$71.6M
RCEL
AVITA Medical Inc
$105.2M
MCRB
Seres Therapeutics Inc
P/E 25.0
$134.6M
GOSS
Gossamer Bio Inc
$717.5M
HURA
TuHURA Biosciences Inc
$45.9M
ANIX
Anixa Biosciences Inc
$102.7M
Earnings
Beat rate: 100.0%
Next Report
May 06, 2026
EPS Estimate: $-0.69
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.69 | — | — |
| Dec 2025 | $-0.88 | $3.65 | +$4.53 |
| Sep 2025 | $-1.21 | $-0.60 | +$0.61 |
| Jun 2025 | $-1.00 | $-0.78 | +$0.22 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -178.5% | -178.5% | -178.5% | -178.5% | -178.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -4796.7% | -4796.7% | -4796.7% | -4796.7% | -4796.7% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | 222.96 | 222.96 | 222.96 | 222.96 | 222.96 |
| Current Ratio | 5.06 | 5.06 | 5.06 | 5.06 | 5.06 | 4.57 |
Key Ratios
ROA (TTM)
-59.8%
P/S (TTM)
14.85
P/B
8.4
EPS (TTM)
$-4.96
52W High
$6.37
52W Low
$1.35
$1.35
52-Week Range
$6.37
How does QTTB compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
QTTB valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
14.9
▲
16%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
8.4
▲
241%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
QTTB profitability vs Biotechnology peers
ROE
-178.5%
▼
165%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-4796.7%
▼
1573%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-59.8%
▼
28%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
QTTB financial health vs Biotechnology peers
D/E ratio
223.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
4.6
▲
3%
above
peers
(4.4)
vs Peers
vs Industry
In line
Beta
0.3
▼
74%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
QTTB fundamentals radar
QTTB
Peer median
Industry
QTTB profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
QTTB vs peers: key metrics
Latest News
No related news yet